FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Home > Pressemitteilung: New pathoblocker is to stop ... Team from the University of Tübingen and the German Center for Infection Research discovers a substance that inhibits signaling pathways of ...

The research teams led by Wolfgang Kastenmüller and Georg Gasteiger utilized advanced microscopy techniques to investigate ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how specific immune cells ...

The granted patents titled “System and Methods For Immune Cells Expansion and Activation In Large Scale” focus on a system and method for culturing and/or activating immune cells in a large scale, ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...